GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 233 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q4 2020. The put-call ratio across all filers is 1.21 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $3,833,000 | -3.5% | 130,949 | +1.8% | 2.28% | -6.8% |
| Q3 2021 | $3,970,000 | -10.2% | 128,649 | +1.9% | 2.44% | -17.5% |
| Q2 2021 | $4,421,000 | -16.6% | 126,249 | -3.0% | 2.96% | -12.2% |
| Q1 2021 | $5,304,000 | -6.9% | 130,149 | -1.1% | 3.37% | -6.3% |
| Q4 2020 | $5,697,000 | -17.2% | 131,549 | +5.5% | 3.60% | -32.5% |
| Q3 2020 | $6,878,000 | -21.4% | 124,749 | -10.0% | 5.33% | -29.0% |
| Q2 2020 | $8,753,000 | +17.0% | 138,649 | -5.3% | 7.52% | +2.2% |
| Q1 2020 | $7,481,000 | -47.0% | 146,429 | -17.5% | 7.35% | -36.1% |
| Q4 2019 | $14,103,000 | +20.1% | 177,414 | -26.7% | 11.50% | -3.1% |
| Q3 2019 | $11,742,000 | -8.8% | 242,014 | -1.2% | 11.86% | +93.0% |
| Q2 2019 | $12,882,000 | -7.8% | 244,914 | -7.2% | 6.14% | +12.7% |
| Q1 2019 | $13,974,000 | +239.9% | 264,014 | +163.7% | 5.45% | +185.7% |
| Q4 2018 | $4,111,000 | -65.4% | 100,129 | -68.0% | 1.91% | -58.9% |
| Q3 2018 | $11,876,000 | -15.0% | 312,514 | +215.9% | 4.65% | -12.9% |
| Q2 2018 | $13,970,000 | – | 98,939 | – | 5.34% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alerce Investment Management, L.P. | 356,270 | $24,262,000 | 23.36% |
| Twin Securities, Inc. | 376,669 | $25,651,000 | 11.94% |
| Paradigm Biocapital Advisors LP | 1,175,879 | $80,077,000 | 10.68% |
| Chicago Capital Management, LLC | 246,246 | $16,769,000 | 9.12% |
| HARVEST MANAGEMENT LLC | 141,500 | $9,636,000 | 7.78% |
| Fernwood Investment Management, LLC | 174,724 | $11,899,000 | 5.02% |
| ArchPoint Investors | 168,725 | $11,490,000 | 4.69% |
| HAVENS ADVISORS LLC | 46,000 | $3,133,000 | 4.69% |
| Perceptive Advisors | 2,322,247 | $158,145,000 | 4.59% |
| Crabel Capital Management, LLC | 112,680 | $7,674,000 | 4.48% |